Is DRTS or DYAI more undervalued in 2026?

CirclFi compares Alpha Tau Medical Ltd. (DRTS) and Dyadic International, Inc. (DYAI) using 13 institutional-grade valuation models. DRTS has a Quality of Company score of 2.3/10 while DYAI scores 6.6/10.

Which is a better buy — DRTS or DYAI?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do DRTS and DYAI valuations compare?

DRTS at $10.13 and DYAI at $0.71 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

DRTS vs DYAI Valuation Comparison 2026 — Intrinsic Value Analysis

DRTS

Biotechnology

Alpha Tau Medical Ltd.

Quality

2.3

out of 10

Value Trap

SAFE

Price

$10.13

Last close

Models

7/13

Active

DYAI

Biotechnology

Dyadic International, Inc.

Quality

6.6

out of 10

Value Trap

SAFE

Price

$0.71

Last close

Models

10/13

Active

Model-by-Model Comparison

Model	Type	DRTS Fair Value	DRTS Upside	DYAI Fair Value	DYAI Upside
Bayesian DCF	Intrinsic	$2.66	-73.7%	$0.24	-66.5%
Earnings Power Value	Intrinsic	—	—	$0.21	-74.0%
EROIC Spread	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
First Chicago	Scenario	$•••.••	••.•%	$•••.••	••.•%
ML-RIV	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
Dynamic NAV	Asset-Based	$•••.••	••.•%	$•••.••	••.•%
PWERM	Option-Based	$10.17	-1.2%	$0.85	+19.8%
Regime Cross-Sectional	Relative	$•••.••	••.•%	$•••.••	••.•%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%
FTNN Topology	Relative	$•••.••	••.•%	$•••.••	••.•%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for DRTS vs DYAI — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

DRTS vs DYAI — Which Stock Is More Undervalued?

DYAI scores higher with a 6.6/10 quality rating vs DRTS's 2.3/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Alpha Tau Medical Ltd. (DRTS) and Dyadic International, Inc. (DYAI) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

DRTS currently trades at $10.13 with a QOC of 2.3/10, while DYAI trades at $0.71 with a QOC of 6.6/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).